Advertisement Isogenica establishes new automation facility - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Isogenica establishes new automation facility

Isogenica, a provider of diagnostic peptides, proteins and antibodies, has established a new automation facility in Chesterford Research Park.

The expansion helps CIS display platform for the discovery of biological therapeutics, diagnostics and reagents using Tecan liquid handling robots and screening equipment.

The development further brings additional capacity to the company for the selection of next generation molecules for biopharmaceutical projects with capacity of up to two hundred selections.

Isogenica CEO Kevin Matthews said their nvestment in this new facility is to accommodate recent increases in activity in their peptide/protein selection platform and to fulfill future demand from both industry and academia.